Patients with acute myeloid leukaemia (AML) present with higher NKG2A expression on peripheral NK cells compared to healthy controls and NKG2A expression correlates with failure to achieve remission [28,29]. The gene discussed is KLRC1; the disease is acute myeloid leukemia.